Trace determination of diethylene glycol (DEG) residue is a critical quality and safety test for glycerin-based pharmaceuticals, cosmetics, e-liquids, and PET food-contact packaging. Because DEG is a potent nephrotoxin with a documented history of mass-poisoning incidents, regulators and pharmacopoeias worldwide enforce strict limits—commonly not more than 0.1% in glycerin and mg/kg-level migration caps for food-contact materials. This article explains the analytical principles, sample types, testing workflows, applicable standards, and practical considerations behind accurate DEG residue analysis at ppm and sub-ppm levels.
Technical Overview
Diethylene glycol (DEG, 2,2'-oxydiethanol, C4H10O3, molecular weight 106.12) is a hygroscopic, water-miscible glycol that enters commercial products in two principal ways: as an unintentional byproduct of ethylene glycol and polyester (PET) manufacturing, or as a deliberate adulterant substituted for the more expensive glycerin. Once absorbed, DEG is metabolized to diglycolic acid, which causes acute tubular necrosis, metabolic acidosis, hepatotoxicity, and central nervous system depression. Repeated poisoning tragedies since 1937—linked to contaminated syrups, elixirs, toothpaste, and cough preparations—have made lot-by-lot DEG testing a cornerstone of pharmaceutical supply-chain control.
Regulatory expectations reflect this hazard profile. Major pharmacopoeias, including the USP Glycerin monograph and the Ph. Eur. Glycerol monograph, restrict DEG in pharmaceutical glycerin to typically not more than 0.1% w/w, and equivalent controls appear in glycerin-related guidance issued by national drug authorities. Food-contact legislation sets specific migration limits for DEG from PET-based packaging in the low-to-tens of mg/kg range, while internal specifications for critical products frequently demand control at 10–100 ppm or lower. Meeting these requirements demands selective, sensitive, validated methods with limits of quantification well below the applicable specification—typically at ppm (mg/kg) or even sub-ppm levels.
Testing Samples
Pharmaceutical Excipients and Formulations
Glycerin (glycerol), propylene glycol, polyethylene glycols, and sorbitol solutions constitute the highest-risk matrix group. Finished-dosage testing covers oral syrups and elixirs, topical gels and creams, suppositories, and softgel capsule shells in which glycerin acts as a plasticizer. These matrices are often viscous and sugar-rich, requiring dilution or extraction strategies that liberate DEG completely while protecting the chromatographic system from non-volatile residues.
Food-Contact Materials and Packaging
Bottle-grade and film-grade PET resins, chips, preforms, and finished containers are tested both for intrinsic DEG content—typically around 1–2 wt% formed during polycondensation—and for DEG migration into aqueous, acidic, and alcoholic food simulants. Standards such as GB/T 17931 for bottle-grade PET resin impose compositional controls, and migration protocols aligned with the GB 31604 series and European food-contact conventions govern the extraction side of the work.
Cosmetics and Personal Care Products
Toothpaste, mouthwash, lotions, makeup removers, and humectant-rich formulations may contain glycerin or propylene glycol derived from suppliers of variable quality. Trace DEG determination verifies raw-material purity and supports finished-product safety assessments required under regional cosmetic regulations.
E-Liquids and Inhaled Products
Electronic cigarette liquids based on propylene glycol and vegetable glycerin are screened for DEG because the inhalation route magnifies the significance of glycol impurities. Specifications typically reference pharmacopoeial or USP-grade solvent purity, supported by e-liquid quality frameworks such as the AFNOR XP D90-300 series.
Industrial and Process Chemicals
Monoethylene glycol product streams, antifreezes, coolants, brake fluids, and triethylene glycol circulating in natural-gas dehydration units are monitored for DEG buildup or cross-contamination. The GB/T 14571 series addresses diethylene glycol determination in industrial ethylene glycol by gas chromatography, and ASTM committee methods such as ASTM E202 support glycol impurity profiling.
Testing Items
Typical scopes of testing offered by accredited third-party laboratories include:
- Identity confirmation of DEG by retention time matching and mass-spectral verification.
- Quantitative DEG content expressed as % w/w, ppm (mg/kg), or µg per unit dose.
- Combined screening for ethylene glycol (MEG) and DEG, as required by pharmacopoeial limit tests.
- Homologous glycol profiling covering MEG, DEG, triethylene glycol, and tetraethylene glycol in a single run.
- Specific migration of DEG from PET packaging into food simulants, reported in mg/kg food or mg/dm² contact area.
- Total DEG in PET resin determined after dissolution, hydrolysis, or methanolysis sample preparation.
- Lot-release attribute testing of glycerin and propylene glycol against pharmacopoeial specifications.
- Method validation packages covering specificity, linearity, LOD/LOQ, accuracy, precision, and robustness.
Testing Methods
Sample Preparation
Straightforward dilute-and-shoot preparation with water, methanol, or acetonitrile suits most excipients and e-liquids. Viscous syrups are diluted with internal-standard solution; creams and suppositories undergo liquid-liquid extraction or solid-phase cleanup to remove lipids. Silylation with BSTFA containing a catalyst converts DEG to its trimethylsilyl ether, sharpening peak shape and boosting detector response for ultra-trace work. PET samples are dissolved in hexafluoroisopropanol or subjected to methanolysis, followed by reprecipitation of polymer and analysis of the liberated glycol fraction. Migration specimens are extracted under time-and-temperature conditions appropriate to the intended food-contact use.
Gas Chromatography with Flame Ionization Detection (GC-FID)
GC-FID on polar polyethylene-glycol (wax-type) capillary columns is the workhorse for pharmacopoeial limit testing, resolving MEG, DEG, triethylene glycol, and glycerin with wide linear dynamic range. Validated LOQs in the range of roughly 10–50 mg/kg are routinely achieved with split or splitless injection and a suitable internal standard such as 1,4-butanediol, which comfortably supports verification against a 0.1% specification.
GC-MS Confirmation and Trace Quantification
Mass-selective detection in selected-ion monitoring mode provides the specificity and sensitivity demanded by complex matrices and sub-ppm specifications. Electron-impact spectra exhibiting characteristic low-mass fragment ions, together with qualifier-ion ratios, confirm identity unambiguously, while validated LOQs down to single-digit or sub-mg/kg levels are attainable with careful injection control and matrix-matched calibration.
Headspace GC Techniques
Static and dynamic headspace sampling minimizes non-volatile matrix burden when co-screening residual solvents alongside glycols. Because DEG boils at approximately 245 °C, elevated equilibration temperatures and salt addition are used to enhance partitioning into the vapor phase; where DEG recovery is inadequate, headspace is retained for volatile co-contaminants while DEG is quantified by direct injection.
Liquid Chromatography Options
HPLC with refractive-index detection offers isocratic quantification of glycols at higher concentration ranges, while evaporative light-scattering and charged-aerosol detectors extend sensitivity. LC-MS/MS serves specialized ultra-trace and bioanalytical investigations where chromatographic selectivity or detector universality of GC is insufficient.
Quality Control and Method Validation
Testing is performed within an ISO/IEC 17025-accredited quality system, with methods validated in accordance with ICH Q2 principles. System suitability requires baseline resolution (typically not less than 1.5) between adjacent glycol peaks; spike-recovery acceptance is commonly 80–120% at trace levels, with precision (RSD) within 5–10%. Calibration employs certified reference materials traceable to national metrology institutes, and reported results include the method used, LOQ, result basis (as-received or dry), measurement uncertainty, and comparison with the applicable limit.
Applications
Trace DEG determination underpins product safety and regulatory compliance across multiple industries:
- Lot-by-lot release of pharmaceutical glycerin and propylene glycol, fulfilling pharmacopoeial limit tests and supply-chain integrity expectations established after historical adulteration events.
- Supplier qualification and periodic surveillance programs that verify declared purity grades for high-risk excipients.
- Process control and specification compliance for PET resin producers, including DEG content trending and its effects on crystallization and mechanical behavior.
- Migration compliance studies for beverage bottles and food packaging submitted under food-contact notification frameworks.
- Safety substantiation for cosmetics, oral-care products, and e-liquids containing glycerin or glycol humectants.
- Industrial troubleshooting, including contamination investigations in glycol process streams, coolants, and gas-dehydration solvent inventories.
- Regulatory submissions and out-of-specification investigations requiring defensible, fully documented analytical data packages.
FAQ
What detection limits can be achieved for DEG residue?
Validated GC-MS methods commonly reach LOQs of 1–10 mg/kg, and sub-mg/kg capability is feasible with derivatization or enrichment techniques. GC-FID typically supports LOQs of about 10–50 mg/kg. Best practice dictates that the LOQ be no more than 10–30% of the applicable specification, so a 0.1% (1000 mg/kg) limit is comfortably covered, and tighter internal limits in the low-ppm range are addressable by GC-MS.
How is DEG distinguished from ethylene glycol, glycerin, and other glycols?
Separation relies on polar wax-phase capillary columns whose selectivity orders low-molecular-weight glycols; derivatization improves symmetry for the most polar analytes. Identity is confirmed by retention-time matching against reference standards and, in GC-MS, by full-scan spectrum and qualifier-ion ratios. System suitability criteria verify resolution before every sequence.
What sample quantities and containers are required?
Liquid samples of 5–20 mL or solids of 5–20 g are typically sufficient for duplicate determination, supplied in clean, tightly sealed HDPE or glass containers. Because glycerin and DEG are strongly hygroscopic, samples should be filled to minimize headspace and protected from moisture pickup. PET chips generally require 20–50 g, and finished packaging articles should be submitted intact.
Must every lot of glycerin be tested for DEG?
Pharmacopoeial monographs impose the limit test on the material, and regulatory guidance in multiple jurisdictions expects identity and DEG limit testing for each incoming lot of glycerin intended for drug products. This lot-level attribute testing is the direct legacy of past adulteration incidents and remains the primary safeguard for supply-chain integrity.
Can DEG and ethylene glycol be quantified in one analysis?
Yes. Optimized GC-FID and GC-MS methods quantify MEG, DEG, and triethylene glycol simultaneously with a single preparation and injection, which is efficient for pharmacopoeial limit tests and impurity profiling alike. Only the extraction and calibration strategy differs across matrix types such as syrups, creams, resins, and simulants.
What is a typical turnaround time and report content?
Standard turnaround is usually five to ten working days from receipt of a fit-for-purpose sample, with expedited options available for release-critical lots. Reports state the analytical method and standard basis, results with units and result basis, the validated LOQ, quality-control recovery data, measurement uncertainty where applicable, and a clear pass-or-fail conclusion against the cited specification.